Wealth Management Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.53M Sell
2,755
-938
-25% -$951K 0.87% 27
2025
Q4
$3.97M Buy
3,693
+5
+0.1% +$4.78K 1.38% 16
2025
Q3
$2.81M Sell
3,688
-28
-0.8% -$20.8K 1% 24
2025
Q2
$2.9M Buy
3,716
+24
+0.7% +$18.6K 1.13% 19
2025
Q1
$3.05M Buy
3,692
+3
+0.1% +$2.5K 1.31% 18
2024
Q4
$2.85M Sell
3,689
-21
-0.6% -$17.4K 1.22% 18
2024
Q3
$3.29M Sell
3,710
-8
-0.2% -$7.19K 1.45% 14
2024
Q2
$3.37M Hold
3,718
1.58% 13
2024
Q1
$3.37M Sell
3,718
-190
-5% -$135K 1.58% 13
2023
Q4
$2.28M Buy
3,908
+83
+2% +$48.4K 1.2% 17
2023
Q3
$2.05M Buy
3,825
+19
+0.5% +$9.79K 1.2% 18
2023
Q2
$1.78M Sell
3,806
-778
-17% -$326K 1.01% 23
2023
Q1
$1.57M Sell
4,584
-63
-1% -$21.2K 0.97% 24
2022
Q4
$1.7M Sell
4,647
-496
-10% -$176K 1.13% 22
2022
Q3
$1.66M Sell
5,143
-66
-1% -$20.9K 1.17% 19
2022
Q2
$1.69M Sell
5,209
-103
-2% -$30.9K 1.15% 20
2022
Q1
$1.52M Hold
5,312
0.86% 24
2021
Q4
$1.47M Sell
5,312
-118
-2% -$29.9K 0.79% 26
2021
Q3
$1.25M Sell
5,430
-47
-0.9% -$11.6K 0.73% 29
2021
Q2
$1.26M Buy
5,477
+1,028
+23% +$206K 0.71% 30
2021
Q1
$831K Buy
4,449
+739
+20% +$145K 0.53% 45
2020
Q4
$626K Buy
3,710
+4
+0.1% +$597 0.41% 56
2020
Q3
$549K Buy
3,706
+4
+0.1% +$619 0.42% 54
2020
Q2
$608K Buy
3,702
+803
+28% +$123K 0.51% 50
2020
Q1
$402K Buy
2,899
+4
+0.1% +$550 0.41% 59
2019
Q4
$380K Buy
2,895
+4
+0.1% +$464 0.27% 85
2019
Q3
$323K Buy
2,891
+4
+0.1% +$445 0.26% 89
2019
Q2
$320K Buy
2,887
+4
+0.1% +$471 0.32% 65
2019
Q1
$374K Buy
+2,883
New +$351K 0.41% 61

Other funds holding LLY

Wealth Management Associates's LLY Position: Q1 2026 in Review

Wealth Management Associates reduced its Eli Lilly (LLY) stake by 25% in Q1 2026, selling an estimated $951K and leaving 2,755 shares worth $2.53M. The position accounts for 0.87% of the portfolio, ranked #27.

Wealth Management Associates first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. The position peaked at $3.97M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Management Associates held 2,755 shares of Eli Lilly worth $2.53M as of Q1 2026.
  • Wealth Management Associates sold 938 Eli Lilly shares in Q1 2026, an estimated $951K.
  • Eli Lilly made up 0.87% of Wealth Management Associates's portfolio in Q1 2026, its #27 holding.
  • Wealth Management Associates first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • Wealth Management Associates's Eli Lilly position peaked at $3.97M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Management Associates's 13F filing for Q1 2026, filed 13 May 2026.